What you believe and what you value as an organization matters. Discover the DNA of our firm.
Get to know our teams and the stories of select staff members who share why they choose to work at Sands Capital.
Read about some of the latest events, partnerships, and business highlights from Sands Capital.
Changing market and geopolitical environments are part of the equation for long-term investors. As active investors, we are prepared to manage through trying times.
Papercup’s proprietary AI dubbing solutions provide high-quality, inexpensive voiceover and video localization.
Executive Managing Director and Sr. Portfolio Manager Brian Christiansen discusses the importance of candor and collaboration in a culture that promotes long-term thinking.
Recruit Holdings is transforming the world of work through wage transparency and providing life-changing opportunities for immigrants and refugees.
Our philosophy is rooted in the belief that, over time, stock prices will reflect the earnings power and growth of the underlying businesses.
Our latest annual report offers a comprehensive view of how we add value through active stewardship.
Our newest strategy takes an unconstrained approach to seeking the best growth businesses outside of the U.S.
Sands Capital invests in innovative businesses across all stages of the growth spectrum
Partner
2021
RA Capital (2020 - 2021)
Boston, MA | Principal, Tools and Diagnostics
Farcast Biosciences / Mitra Biotech (2015 - 2020)
Woburn, MA | Head of Strategy, Chief Commercial Officer
RA Capital (2015)
Boston, MA | Entrepreneur in Residence
Becton Dickinson (2006 - 2014)
Franklin Lakes, NJ | VP
Serologicals / Upstate Biotechnology (2000 - 2006)
Charlottesville, VA | VP
Pratt & Whitney (1996 - 1998)
Hartford, CT | Manufacturing Engineer
University of Virginia (2000)
MBA | Darden School
Boston University (1995)
BS | Mechanical Engineering
Parker is a Partner of the Sands Capital Life Sciences Pulse Strategy and joined Sands Capital in 2021. Parker has 20 years of operational experience with life science tools, diagnostics and device companies in a range of commercial, development and general management roles. In those roles, he’s been accountable for revenue ranging from launch up to $70M annually, he’s led acquisitions and integrations and he’s designed and executed multiple clinical trials. He has been an advisor, investor and board member for private life science companies since 2015. Parker has a degree in Mechanical Engineering from Boston University and an MBA from the Darden School at the University of Virginia.
Something has gone wrong, check that all fields have been filled in correctly. If you have adblock, disable it.